Journal
ANDROLOGY
Volume 4, Issue 4, Pages 616-625Publisher
WILEY
DOI: 10.1111/andr.12156
Keywords
anogenital distance; endocrine disrupters; masculanizing programming window; prenatal androgen exposure; testicular dysgenesis syndrome; testis development
Categories
Funding
- European Union
- World Cancer Research Fund International
- Medical Research Council (UK)
- Newlife Foundation
- Mothercare Foundation
- Evelyn Trust
- NIHR Cambridge Biomedical Research Centre
- International Center for Research and Research Training in Endocrine Disrupting Effects on Male Reproduction and Child Health (EDMaRC), Department of Growth and Reproduction, Rigshospitalet, University of Copenhagen, Denmark
- Medical Research Council [MC_U106179472, MC_UU_12015/2] Funding Source: researchfish
- MRC [MC_U106179472, MC_UU_12015/2] Funding Source: UKRI
Ask authors/readers for more resources
Abnormal foetal testis development has been proposed to underlie common disorders of the male reproductive system such as cryptorchidism, hypospadias, reduced semen quality and testicular germ cell tumour, which are regarded as components of a 'testicular dysgenesis syndrome'. The increasing trends and geographical variation in their incidence have been suggested to result from in utero exposure to environmental chemicals acting as endocrine disruptors. In rodents, the anogenital distance (AGD), measured from the anus to the base of genital tubercle, is a sensitive biomarker of androgen exposure during a critical embryonic window of testis development. In humans, several epidemiological studies have shown alterations in AGD associated with prenatal exposure to several chemicals with potential endocrine disrupting activity. However, the link between AGD and androgen exposure in humans is not well-defined. This review focuses on the current evidence for such a relationship. As in rodents, a clear gender difference is detected during foetal development of the AGD in humans which is maintained thereafter. Reduced AGD in association with clinically relevant outcomes of potential environmental exposures, such as cryptorchidism or hypospadias, is in keeping with AGD as a marker of foetal testicular function. Furthermore, AGD may reflect variations in prenatal androgen exposure in healthy children as shorter AGD at birth is associated with reduced masculine play behaviour in preschool boys. Several studies provide evidence linking shorter AGD with lower fertility, semen quality and testosterone levels in selected groups of adults attending andrology clinics. Overall, the observational data in humans are consistent with experimental studies in animals and support the use of AGD as a biomarker of foetal androgen exposure. Future studies evaluating AGD in relation to reproductive hormones in both infants and adults, and to gene polymorphisms, will help to further delineate the effect of prenatal and postnatal androgen exposures on AGD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available